病例报告:帕佐帕尼布诱导的急性冠状动脉综合征
Adithya K Yadalam1, William M Schultz1, Chanhee Han2,3
1Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.
帕佐帕尼布是一种癌症药物,通过促进动脉血栓形成,可能直接导致急性冠状动脉综合征 (ACS). 这一案例凸显了在向癌症患者开处方巴佐帕尼布之前评估心血管风险的重要性.
科学领域:
- 心脏瘤学是一门专业.
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 帕佐帕尼布抑制血管内皮生长因子受体,治疗转移性细胞癌和软组织肉瘤.
- 现有的指导方针表明,巴佐帕尼布有急性冠状动脉综合征 (ACS) 的风险,但其在动脉血栓形成中的直接作用尚不清楚.
- 在先前的试验中对冠状动脉疾病的有限评估阻碍了最终的因果关系评估.
更多相关视频
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
相关概念视频
Acute Coronary SyndromeI: Introduction
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations
Acute Coronary Syndrome III: Diagnostic studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
